Clorox (CLX) reported fiscal Q2 adjusted earnings late Monday of $1.55 per diluted share, down from $2.16 a year earlier.
Analysts surveyed by FactSet expected $1.40.
Sales for the quarter ended Dec. 31 were $1.69 billion, down from $1.99 billion a year earlier.
Analysts polled by FactSet expected $1.63 billion.
The company expects fiscal year 2025 adjusted earnings of $6.95 to $7.35 per diluted share, compared with its prior outlook of $6.65 to $6.90. Analysts surveyed by FactSet expect $6.86.
The company expects net sales for the year to be down 1% to up 2%, versus its previous outlook for a decline of mid- to high-single digits. Analysts surveyed by FactSet expect $7.05 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.